Physician profile
Stuart Holden
NPI 1013941483
$1,065,464.46
in general payments reported to CMS, 2019-2025
4 companies · $397K in 2025
The $397K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $195K · 2022: $127K · 2023: $188K · 2024: $158K · 2025: $397K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $723K · Travel and Lodging: $18K · Food and Beverage: $2,134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $723,083.70 |
| Travel and Lodging | $18,076.20 |
| Food and Beverage | $2,133.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $1,064,875.39 | 2021-2025 | |
| Rochester Medical Corporation | $377.65 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $184.35 | 2023 | Bard Urinary Drainage Bag |
| Becton, Dickinson and Company | $27.07 | 2024 | Bard Urinary Drainage Bag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Holden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.